These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 24995409)

  • 41. The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation.
    Ono Y; Yoshimura M; Hirata K; Yamauchi C; Toi M; Suzuki E; Takada M; Hiraoka M; Mizowaki T
    Radiat Oncol; 2019 Jul; 14(1):121. PubMed ID: 31291997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy.
    Neuschatz AC; DiPetrillo T; Safaii H; Price LL; Schmidt-Ullrich RK; Wazer DE
    Cancer; 2003 Jan; 97(1):30-9. PubMed ID: 12491502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Full-thickness closure in breast-conserving surgery: the impact on radiotherapy target definition for boost and partial breast irradiation. A multimodality image evaluation.
    den Hartogh MD; van den Bongard HJ; Davidson MT; Kotte AN; Verkooijen HM; Philippens ME; van Vulpen M; van Asselen B; Pignol JP
    Ann Surg Oncol; 2014 Nov; 21(12):3774-9. PubMed ID: 24874499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer.
    Fastner G; Gaisberger C; Kaiser J; Scherer P; Ciabattoni A; Petoukhova A; Sperk E; Poortmans P; Calvo FA; Sedlmayer F; Leonardi MC
    Radiother Oncol; 2020 Aug; 149():150-157. PubMed ID: 32413529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?
    Aurilio G; Bagnardi V; Graffeo R; Nolè F; Petit JY; Locatelli M; Martella S; Iera M; Rey P; Curigliano G; Rotmensz N; Munzone E; Goldhirsch A
    Anticancer Res; 2014 Nov; 34(11):6677-83. PubMed ID: 25368274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neoadjuvant chemotherapy in locally advanced breast cancer.
    Iqbal J; Shafi AA; Alharthi BN
    J Coll Physicians Surg Pak; 2014 Nov; 24(11):845-8. PubMed ID: 25404445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis.
    Park S; Park JM; Cho JH; Park HS; Kim SI; Park BW
    Ann Surg Oncol; 2013 Sep; 20(9):2858-65. PubMed ID: 23645483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor bed boost omission after negative re-excision in breast-conservation treatment.
    Arthur DW; Cuttino LW; Neuschatz AC; Koo DT; Morris MM; Bear HD; Kaplan BJ; Dawson K; Wazer DE
    Ann Surg Oncol; 2006 Jun; 13(6):794-801. PubMed ID: 16614879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
    Ryu JM; Park S; Paik HJ; Nam SJ; Kim SW; Lee SK; Yu J; Bae SY; Kim I; Bang SI; Mun GH; Pyon JK; Jeon BJ; Lee JE
    Clin Breast Cancer; 2017 Jun; 17(3):204-210. PubMed ID: 28065399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.
    Polgár C; Fodor J; Major T; Sulyok Z; Kásler M
    Radiother Oncol; 2013 Aug; 108(2):197-202. PubMed ID: 23742961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.
    Solá M; Margelí M; Castellá E; Cirauqui B; Mariscal A; Rull M; Julian JF; Luna M; Vallejo V; Fraile M
    Breast; 2013 Oct; 22(5):908-13. PubMed ID: 23683695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Left-Sided Breast Irradiation does not Result in Increased Long-Term Cardiac-Related Mortality Among Women Treated with Breast-Conserving Surgery.
    Paul Wright G; Drinane JJ; Sobel HL; Chung MH
    Ann Surg Oncol; 2016 Apr; 23(4):1117-22. PubMed ID: 26530446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eleven-year follow-up results in the delay of breast irradiation after conservative breast surgery in node-negative breast cancer patients.
    Vujovic O; Yu E; Cherian A; Dar AR; Stitt L; Perera F
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):760-4. PubMed ID: 16246494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is oncoplastic surgery a contraindication for accelerated partial breast radiation using the interstitial multicatheter brachytherapy method?
    Roth AM; Kauer-Dorner D; Resch A; Schmid A; Thill M; Niehoff P; Melchert C; Berger D; Kovács G;
    Brachytherapy; 2014; 13(4):394-9. PubMed ID: 24946973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathological lymph node involvement at surgery is a significant predictive factor of recurrence in locally advanced breast cancer treated with concomitant epirubicin-docetaxel neoadjuvant chemotherapy: a cohort study.
    Kai K; Arima N; Miyayama H; Yamamoto Y; Iwase H; Nishimura R
    Breast Cancer; 2009; 16(1):42-8. PubMed ID: 18504642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intraoperative Tumor Bed Boost With Electrons in Breast Cancer of Clinical Stages I Through III: Updated 10-Year Results.
    Kaiser J; Kronberger C; Moder A; Kopp P; Wallner M; Reitsamer R; Fischer T; Fussl C; Zehentmayr F; Sedlmayer F; Fastner G
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):92-101. PubMed ID: 29970317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-dose-rate brachytherapy boost effect on local tumor control in young women with breast cancer.
    Guinot JL; Baixauli-Perez C; Soler P; Tortajada MI; Moreno A; Santos MA; Mut A; Gozalbo F; Arribas L
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):165-71. PubMed ID: 25446608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II study on breast conservative surgery plus chemo- and radiotherapy in treating Chinese patients with early staged breast cancer.
    Liu YC; Zhou SB; Gao F; Yin XX; Zhao Y; Huang XE
    Asian Pac J Cancer Prev; 2013; 14(6):3747-50. PubMed ID: 23886176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.